CDK4/6/BRD4-IN-1
CDK4/6/BRD4-IN-1 (B15) is an inhibitor of CDK4, CDK6 and BRD4, with IC50 values of 220 nM, 146 nM, 106 nM and 85 nM for BRD4-BD2, BRD4-BD1, CDK6 and CDK4, respectively. CDK4/6/BRD4-IN-1 (B15) can be used in the study of NSCLC (Non-Small Cell Lung Cancer) . CDK4/6/BRD4-IN-1 (B15) induces cell cycle arrest and apoptosis[1].
Product Specifications
UNSPSC
12352005
Target
CDK; Epigenetic Reader Domain
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Field of Research
Cancer
Smiles
O=C(C1=CC2=CN=C(NC3=NC=C(N4CCN(C(COC5=C(OC)C=C(C(N6)=NC7=C(C=C(F)C=C7)C6=O)C=C5OC)=O)CC4)C=C3)N=C2N1C8CCCC8)N(C)C
Molecular Formula
C41H43FN10O6
Molecular Weight
790.84
References & Citations
[1]Yonglei Zhang, et al. Discovery of dual CDK4/6 and BRD4 inhibitor as apoptosis and autophagy inducers against NSCLC in vitro and in vivo. Eur J Med Chem. 2025 Jun 5:290:117495.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BD1; BD2; CDK4; CDK6
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC472167-500 1x 500 µL
Emerin (Papillary Thyroid Carcinoma and EDMD Marker) (EMD/2167), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682387-500 1x 500 µL
SOX9 / SRY-box 9 (SOX9/2387), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details